Info@ThinkPinkRocks.com

Adjuvant chemotherapy use benefits early-stage NSCLC patients

The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 – 7 cm.

Visit link:
Adjuvant chemotherapy use benefits early-stage NSCLC patients

Share

Leave a Reply